Recently, second-generation anti-VEGF agents, including brolucizumab, faricimab, and 8 mg aflibercept, have become available ...

Diabetes is one of the fastest-growing health problems in India today. It occurs when the level of sugar (glucose) in the ...

La Roche Limited (Roche Canada) is pleased to announce today that VABYSMO® (faricimab injection) is now publicly funded for ...

Macular edema (ME), a leading cause of central vision loss, is often treated with anti-vascular endothelial growth factor ...

For those who received the thiazolidinedione, the risk of macular edema was 5 times greater than those who did not receive pioglitazone.

An intravitreal implant shows promise in enhancing visual function and retinal structure in diabetic retinopathy patients, ...